InvestorsHub Logo
Followers 0
Posts 412
Boards Moderated 0
Alias Born 08/05/2016

Re: James salmon post# 44132

Monday, 11/27/2017 11:44:30 AM

Monday, November 27, 2017 11:44:30 AM

Post# of 108192
James, as the most trusted and respected poster here, may I pick your brain about the previously failed PD1 patients included in our trials. Do you happen to know those specific patients (ones who previously failed PD1) what their percentage/numbers were who survived ADXS trials? You make a good point that ADXS may be good for these people. I am just wondering if the trial data show their group benefited as much as others. TIA
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News